![Philippe Weigerstorfer](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: - $ in data 31/05/2026
Philippe Weigerstorfer is Chairman at Onycho Pharma Pte Ltd. since 2020 and Independent Director at Sonoma Pharmaceuticals, Inc. since 2018.
Former roles include Executive Chairman at Galencia AB from 2000 to 2016, Managing Director at Vifor Pharma Asia Pacific Pte Ltd. from 2011 to 2017, Head-Corporate Development Division at Corden Pharma Fribourg SA from 1999 to 2011, Head-Corporate Marketing & Dermatology at Novartis AG from 1996 to 1999, Director at Aspreva Pharmaceuticals Corp., Head-Dermatology & Cardiovascular at Sandoz Pharmaceuticals AG.
Education includes undergraduate studies at the University of Basel.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 23/04/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| SONOMA PHARMACEUTICALS, INC. | Direttore/Membro del Consiglio | 19/09/2018 |
Onycho Pharma Pte Ltd. | Presidente | 01/01/2020 |
| Società | Posizione | Fine |
|---|---|---|
Vifor Pharma Asia Pacific Pte Ltd.
 Vifor Pharma Asia Pacific Pte Ltd. Pharmaceuticals: MajorHealth Technology Manufactures iron, kidney and cardio renal medicines | Amministratore Delegato | 01/01/2017 |
Galencia AB | Presidente | 01/01/2016 |
| VIFOR PHARMA | Corporate Officer/Principal | 01/07/2011 |
| NOVARTIS AG | Corporate Officer/Principal | 01/01/1999 |
Sandoz Pharmaceuticals AG
 Sandoz Pharmaceuticals AG BiotechnologyHealth Technology Develops and produces biopharmaceuticals | Corporate Officer/Principal | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 9 |
|---|---|
Sonoma Pharmaceuticals, Inc.
 Sonoma Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and sells stabilized hypochlorous acid | Health Technology |
Aspreva Pharmaceuticals Corp.
 Aspreva Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Novartis AG
 Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
Vifor Pharma AG
 Vifor Pharma AG Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products and provides logistical & database services | Health Technology |
University of Basel
 University of Basel Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sandoz Pharmaceuticals AG
Sandoz Pharmaceuticals AG BiotechnologyHealth Technology Develops and produces biopharmaceuticals | Health Technology |
Onycho Pharma Pte Ltd. | |
Vifor Pharma Asia Pacific Pte Ltd.
Vifor Pharma Asia Pacific Pte Ltd. Pharmaceuticals: MajorHealth Technology Manufactures iron, kidney and cardio renal medicines | Health Technology |
Galencia AB |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
